InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
58,030.54
(
0.24%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

laraz5

Send PM Follow Ignore
Followers 49
Posts 8451
Boards Moderated 3
Alias Born 02/11/2008

laraz5

Re: None

Wednesday, 09/06/2017 2:14:18 PM

Wednesday, September 06, 2017 2:14:18 PM

Post# of 21373
So what happened when Novartis researched

human prolactin receptor antagonist?

Well, lets see an Actual company had 73 participants

And It couldnt pass phase 1

So AEPP Needs to give it a rest



http://theoncologist.alphamedpress.org/content/early/2016/04/18/theoncologist.2015-0502.abstract


imo

Everything I post, is In my own opinion, I don't care what you think about it, if you disagree, post it like I do. If you buy or sell stock based on what I say, your a lunatic and should not be trading. Have a great day!

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up